应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CTXR Citius Pharmaceuticals, Inc.
休市中 12-20 15:59:59 EST
2.60
+0.03
+1.17%
盘后
2.57
-0.03
-1.15%
19:30 EST
最高
2.74
最低
2.48
成交量
10.00万
今开
2.50
昨收
2.57
日振幅
10.12%
总市值
2,009万
流通市值
1,882万
总股本
772.72万
成交额
26.17万
换手率
1.38%
流通股本
724.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Citius Pharmaceuticals, Inc.盘中异动 快速上涨5.45%
市场透视 · 12-21 02:54
Citius Pharmaceuticals, Inc.盘中异动 快速上涨5.45%
Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.19%
市场透视 · 12-19
Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.19%
Citius Pharmaceuticals, Inc.盘中异动 股价大跌5.04%
市场透视 · 12-17
Citius Pharmaceuticals, Inc.盘中异动 股价大跌5.04%
Citius Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.94%
市场透视 · 12-13
Citius Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.94%
Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌8.26%报3.00美元
市场透视 · 12-11
Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌8.26%报3.00美元
Citius Pharmaceuticals, Inc.盘中异动 下午盘急速下挫5.11%
市场透视 · 12-10
Citius Pharmaceuticals, Inc.盘中异动 下午盘急速下挫5.11%
Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.01%
市场透视 · 12-06
Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.01%
Citius Pharmaceuticals, Inc.盘中异动 急速下挫5.77%报3.35美元
市场透视 · 12-04
Citius Pharmaceuticals, Inc.盘中异动 急速下挫5.77%报3.35美元
嗡嗡声--美国股票走势-贝莱德、Terns Pharma、PSQ Holdings
路透中文 · 12-03
嗡嗡声--美国股票走势-贝莱德、Terns Pharma、PSQ Holdings
Citius Pharmaceuticals, Inc.盘中异动 股价大跌8.43%报3.04美元
市场透视 · 12-02
Citius Pharmaceuticals, Inc.盘中异动 股价大跌8.43%报3.04美元
Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌11.57%
市场透视 · 11-27
Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌11.57%
Citius Pharmaceuticals, Inc.盘中异动 大幅拉升7.27%
市场透视 · 11-26
Citius Pharmaceuticals, Inc.盘中异动 大幅拉升7.27%
Citius Pharmaceuticals, Inc.股价上涨30.34% 市值涨1022.18万美元
市场透视 · 11-25
Citius Pharmaceuticals, Inc.股价上涨30.34% 市值涨1022.18万美元
BUZZ--美国股票走势-CC 控股公司、世邦魏理仕、莱克西康制药公司
Reuters · 11-23
BUZZ--美国股票走势-CC 控股公司、世邦魏理仕、莱克西康制药公司
BUZZ--美国股票走势-Jet.AI, SL Green, WTW
路透中文 · 11-23
BUZZ--美国股票走势-Jet.AI, SL Green, WTW
BUZZ-Citius 制药公司宣布反向股票分割后下跌
路透中文 · 11-22
BUZZ-Citius 制药公司宣布反向股票分割后下跌
Citius Pharmaceuticals, Inc.股价重挫18.17% 市值跌473.09万美元
市场透视 · 11-22
Citius Pharmaceuticals, Inc.股价重挫18.17% 市值跌473.09万美元
Citius Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.94%报0.180美元
市场透视 · 11-21
Citius Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.94%报0.180美元
Citius Pharmaceuticals, Inc.盘中异动 股价大涨5.58%报0.203美元
市场透视 · 11-20
Citius Pharmaceuticals, Inc.盘中异动 股价大涨5.58%报0.203美元
Citius Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.22%报0.213美元
市场透视 · 11-19
Citius Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.22%报0.213美元
加载更多
公司概况
公司名称:
Citius Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Citius Pharmaceuticals, Inc.于2007年1月23日成立为马萨诸塞州有限责任公司Citius Pharmaceuticals,LLC。总部位于新泽西州克兰福德的公司是一家致力于重症监护产品开发和商业化的专业制药公司针对重要的医疗需求,重点是辅助癌症护理和独特处方产品中的抗感染产品。他们的目标是通过提供解决未满足的医疗需求的治疗产品来实现领先的市场地位。以前批准的具有重要安全性和有效性数据的药物的新配方是寻求减少与药物开发相关的发展和临床风险的核心焦点。他们的战略以具有知识产权和监管排他性保护的产品为中心,同时提供优于其他现有治疗方法的竞争优势。
发行价格:
--
{"stockData":{"symbol":"CTXR","market":"US","secType":"STK","nameCN":"Citius Pharmaceuticals, Inc.","latestPrice":2.6,"timestamp":1734728399999,"preClose":2.57,"halted":0,"volume":100043,"hourTrading":{"tag":"盘后","latestPrice":2.57,"preClose":2.6,"latestTime":"19:30 EST","volume":1074,"amount":2763.62,"timestamp":1734741035421},"delay":0,"floatShares":7240000,"shares":7727184,"eps":-6.110375,"marketStatus":"休市中","marketStatusCode":7,"change":0.03,"latestTime":"12-20 15:59:59 EST","open":2.5,"high":2.74,"low":2.48,"amount":261671.550404,"amplitude":0.101167,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.110375,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"adjPreClose":2.57,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.53,"preClose":2.57,"latestTime":"09:19 EST","volume":791,"amount":2010.386379,"timestamp":1734704393469},"postHourTrading":{"tag":"盘后","latestPrice":2.57,"preClose":2.6,"latestTime":"19:30 EST","volume":1074,"amount":2763.62,"timestamp":1734741035421},"volumeRatio":0.8297282341033789,"impliedVol":0.6975,"impliedVolPercentile":0.0518},"requestUrl":"/m/hq/s/CTXR","defaultTab":"news","newsList":[{"id":"2493478585","title":"Citius Pharmaceuticals, Inc.盘中异动 快速上涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493478585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493478585?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:54","pubTimestamp":1734720888,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日02时54分,Citius Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.45%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。其相关个股中,Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.、Prelude Therapeutics Incorporated涨幅较大,Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为2648.63%、488.41%、122.07%,振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为173.15%、163.64%、108.00%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122102544895ea9fee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122102544895ea9fee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTXR"],"gpt_icon":0},{"id":"2492138743","title":"Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492138743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492138743?lang=zh_cn&edition=full","pubTime":"2024-12-19 00:05","pubTimestamp":1734537921,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日00时05分,Citius Pharmaceuticals, Inc.股票出现波动,股价快速下挫5.19%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,Polyrizon Ltd.、Cognition Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为2608.59%、514.05%、296.51%,振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为227.62%、118.27%、66.83%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219000521ab8230b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219000521ab8230b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTXR","BK4007"],"gpt_icon":0},{"id":"2492969729","title":"Citius Pharmaceuticals, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492969729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492969729?lang=zh_cn&edition=full","pubTime":"2024-12-17 23:16","pubTimestamp":1734448560,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日23时16分,Citius Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.04%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Marker Therapeutics, Inc.涨幅较大,Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Polyrizon Ltd.较为活跃,换手率分别为1721.22%、201.88%、100.59%,振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Portage Biotech Inc.,振幅分别为113.21%、95.10%、78.77%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217231601a1f61e31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217231601a1f61e31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTXR"],"gpt_icon":0},{"id":"2491737136","title":"Citius Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491737136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491737136?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:10","pubTimestamp":1734102651,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时10分,Citius Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.94%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Oculis Holding Ag C/Wts 06/03/2028 、Cardiff Oncology, Inc.、Mesoblast Ltd涨幅较大,Aptevo Therapeutics Inc.、Palisade Bio, Inc.、Candel Therapeutics, Inc.较为活跃,换手率分别为45.66%、41.51%、28.25%,振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Tc Biopharm Plc C/Wts 10/02/2028 、Jupiter Neurosciences, Inc.,振幅分别为43.12%、39.33%、36.85%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213231051a1ec45c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213231051a1ec45c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTXR","BK4007"],"gpt_icon":0},{"id":"2490697108","title":"Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌8.26%报3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490697108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490697108?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:37","pubTimestamp":1733931430,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时37分,Citius Pharmaceuticals, Inc.股票出现异动,股价快速下挫8.26%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.73%。其相关个股中,Candel Therapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为430.09%、166.64%、102.28%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Candel Therapeutics, Inc.、Biora Therapeutics, Inc.,振幅分别为127.38%、103.04%、69.68%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211233710ab6febee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211233710ab6febee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTXR","BK4007"],"gpt_icon":0},{"id":"2490077327","title":"Citius Pharmaceuticals, Inc.盘中异动 下午盘急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490077327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490077327?lang=zh_cn&edition=full","pubTime":"2024-12-10 04:13","pubTimestamp":1733775183,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日04时13分,Citius Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.11%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,Metagenomi, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Sonnet Biotherapeutics Holdings, Inc.涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Metagenomi, Inc.、Reviva Pharmaceuticals Holdings, Inc.较为活跃,换手率分别为5581.91%、152.36%、57.67%,振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Reviva Pharmaceuticals Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为224.91%、154.55%、146.31%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121004130495e875ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121004130495e875ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTXR","BK4007"],"gpt_icon":0},{"id":"2489423777","title":"Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489423777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489423777?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:57","pubTimestamp":1733500669,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时57分,Citius Pharmaceuticals, Inc.股票出现异动,股价急速下跌6.01%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,Surrozen Inc C/Wts 01/08/2031 、Adc Therapeutics Sa、Cervomed Inc.涨幅较大,Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃,换手率分别为59.89%、44.51%、36.62%,振幅较大的相关个股有Adc Therapeutics Sa、Tc Biopharm Plc C/Wts 10/02/2028 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为40.01%、38.67%、36.94%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206235750a1d999da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206235750a1d999da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTXR"],"gpt_icon":0},{"id":"2488190800","title":"Citius Pharmaceuticals, Inc.盘中异动 急速下挫5.77%报3.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488190800","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488190800?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:48","pubTimestamp":1733323736,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时48分,Citius Pharmaceuticals, Inc.股票出现异动,股价快速下挫5.77%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。其相关个股中,Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃,换手率分别为1884.99%、210.30%、118.00%,振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Eterna Therapeutics Inc.、Heron Therapeutics, Inc.,振幅分别为237.89%、48.53%、34.75%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120422485698e55dc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120422485698e55dc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTXR","BK4007"],"gpt_icon":0},{"id":"2488942699","title":"嗡嗡声--美国股票走势-贝莱德、Terns Pharma、PSQ Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2488942699","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488942699?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:50","pubTimestamp":1733241022,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30,道琼斯工业平均指数.DJI下跌0.29%,报44,650.91点;标准普尔500指数.SPX下跌0.20%,报6,034.81点;纳斯达克综合指数.IXIC下跌0.10%,报19,384.43点。标准普尔500指数.PG.INX涨幅前三名是: ** Palantir Technologies Inc PLTR.OQ,上涨 5.4. nL3N3N414G ** Credo Technology Group Holding Ltd CRDO.O:BUZZ - 因第二季度销售额超出预期而大涨 nL3N3N40QR ** Janux Therapeutics Inc JANX.O:BUZZ - 因癌症药物的早期数据超出预期而飙升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3S3N419A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","CZR","LTRN","PSQH","LU1923622291.USD","KR","LU2430703095.HKD","TCS","TERN","LU2125909759.SGD","MCHP","ZS","OMEX","CPNG","ATIP","CANG","LEV","LYV","AMGN","CTNT","CRDO","JANX","IE00BJJMRZ35.SGD","MP","BK4168","BLK","BK4135","ROIV","NEM","BK4114","AXON","DECK","MPLN","X","BK4187","CTXR","CTRN","CHRS","T","LU1861220033.SGD","IE00B4R5TH58.HKD","AZO","FDX","OLLI","PCG","LU2264538146.SGD"],"gpt_icon":1},{"id":"2488467216","title":"Citius Pharmaceuticals, Inc.盘中异动 股价大跌8.43%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488467216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488467216?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:36","pubTimestamp":1733150174,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时36分,Citius Pharmaceuticals, Inc.股票出现波动,股价大幅下挫8.43%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.05%。其相关个股中,Senti Biosciences, Inc.、Purple Biotech Ltd、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Senti Biosciences, Inc.、Purple Biotech Ltd、Revelation Biosciences, Inc.较为活跃,换手率分别为769.33%、705.03%、207.38%,振幅较大的相关个股有Senti Biosciences, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cabaletta Bio, Inc.,振幅分别为49.54%、31.58%、21.73%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223614a2669b4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223614a2669b4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTXR"],"gpt_icon":0},{"id":"2486827091","title":"Citius Pharmaceuticals, Inc.盘中异动 早盘股价大跌11.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486827091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486827091?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:31","pubTimestamp":1732717897,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时31分,Citius Pharmaceuticals, Inc.股票出现异动,股价急速下跌11.57%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Cyclerion Therapeutics, Inc.、Tuhura Biosciences, Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Molecular Templates, Inc.较为活跃,换手率分别为792.82%、25.07%、6.89%,振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Elevai Labs, Inc.、Molecular Templates, Inc.,振幅分别为13.97%、8.20%、8.16%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223137abe369c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223137abe369c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTXR"],"gpt_icon":1},{"id":"2486854001","title":"Citius Pharmaceuticals, Inc.盘中异动 大幅拉升7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486854001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486854001?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:30","pubTimestamp":1732631443,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时30分,Citius Pharmaceuticals, Inc.股票出现波动,股价快速上涨7.27%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Poseida Therapeutics, Inc.、Caribou Biosciences, Inc.、Arrowhead Pharmaceuticals, Inc.涨幅较大,Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为12.68%、9.30%、9.25%,振幅较大的相关个股有Cardio Diagnostics Holdings Inc.、Bioline Rx Ltd、Inozyme Pharma, Inc.,振幅分别为9.38%、7.62%、4.73%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622304398e44a31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622304398e44a31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTXR"],"gpt_icon":0},{"id":"2486080068","title":"Citius Pharmaceuticals, Inc.股价上涨30.34% 市值涨1022.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486080068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486080068?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545143,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分,Citius Pharmaceuticals, Inc.股票出现异动,股价大幅上涨30.34%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.97%。其相关个股中,Scholar Rock Holding Corporation、Citius Pharmaceuticals, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为85.70%、54.70%、34.34%,振幅较大的相关个股有Scholar Rock Holding Corporation、Citius Pharmaceuticals, Inc.、Nkgen Biotech, Inc.,振幅分别为13.36%、12.03%、11.09%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223224abddfa39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223224abddfa39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTXR","BK4007"],"gpt_icon":0},{"id":"2485929061","title":"BUZZ--美国股票走势-CC 控股公司、世邦魏理仕、莱克西康制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2485929061","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485929061?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:48","pubTimestamp":1732301316,"startTime":"0","endTime":"0","summary":"** Arm Holdings PLC : BUZZ - 富国银行将其评级定为 \"增持\"。** Copart Inc : BUZZ - 因飓风过后的销售而实现季度营收增长。** Tapestry Inc : BUZZ - 在 20 亿美元的加速股票回购计划后涨至逾十年新高 ** Eyenovia Inc : BUZZ - 因采取更多削减成本行动和推迟债务偿还而上涨 ** Reddit Inc : BUZZ - 在腾讯披露股票销售后从创纪录水平回落。** Viking Therapeutics Inc : BUZZ--上涨;B.Riley给予 \"买入 \"评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTU","SLG","FLEX","ROST","CTXR","DJX","LXRX","CYH","BKE","CBRE","VTRS","CBG","AMIX","WAY",".DJI","CC","NTAP","HCA","CPRT","AXP","APG","QID","DOG","EYEN",".IXIC","EOG","JTAI","LIPO","QLD","HALO","FFWM","VKTX","HON","WTW","TPR",".SPX","PSQ","RUN","THC","NEM"],"gpt_icon":1},{"id":"2485298286","title":"BUZZ--美国股票走势-Jet.AI, SL Green, WTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298286","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298286?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:09","pubTimestamp":1732291794,"startTime":"0","endTime":"0","summary":".N美东时间10:30,道琼斯工业平均指数.DJI上涨0.38%,报44038.76点。标普500指数.SPX持平于0%,报5948.51点;纳斯达克综合指数.IXIC下跌0.34%,报18908.67点。标准普尔 500 指数.PG.INX涨幅前三名是: ** 超级微型计算机公司SMCI.O,上涨 10.6. ** 莫德纳 Inc MRNA.O,上涨 5.6 标准普尔 500 指数.PL.INX跌幅前三名: ** Intuit Inc INTU.O,下跌 4.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4S3MT187:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","VKTX","BK4585","EOG","JTAI","EYEN","LU0823426308.USD","HON","LU0070302665.USD","VTRS","SLG","CPRT","HALO","FFWM","THC","FLEX","LU1880383440.USD","NEM","LU0289961442.SGD","BK4023","LU0348788117.USD","WTW","ROST","INTU","LU0124676726.USD","HUT","LU0444971666.USD","HCA","RUN","LU2023251221.USD","LU0949170772.SGD","NTAP","TPR","LU0821914370.USD","LIPO","LU0143863784.USD","LU0109392836.USD","BK4139","CYH","LU0072462343.USD","BKE"],"gpt_icon":1},{"id":"2485643002","title":"BUZZ-Citius 制药公司宣布反向股票分割后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2485643002","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485643002?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:56","pubTimestamp":1732287405,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4S3MT155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4112","IE00BKPKM429.USD","LU2095319765.USD","LU2210150020.SGD","BK4585","IE00B64PRP62.GBP","CTXR","BK4588","IE00BGHQF748.EUR","BK4007"],"gpt_icon":0},{"id":"2485626154","title":"Citius Pharmaceuticals, Inc.股价重挫18.17% 市值跌473.09万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485626154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485626154?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:31","pubTimestamp":1732285871,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时31分,Citius Pharmaceuticals, Inc.股票出现波动,股价急速跳水18.17%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。其相关个股中,Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Replimune Group, Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Exicure, Inc.较为活跃,换手率分别为499.28%、61.77%、35.49%,振幅较大的相关个股有Exicure, Inc.、Virpax Pharmaceuticals, Inc.、Kairos Pharma, Ltd.,振幅分别为10.96%、9.21%、9.19%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223111a24e2019&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223111a24e2019&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTXR","BK4007"],"gpt_icon":0},{"id":"2485979384","title":"Citius Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.94%报0.180美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485979384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485979384?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:31","pubTimestamp":1732199498,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时31分,Citius Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.94%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Conduit Pharmaceuticals Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Conduit Pharmaceuticals Inc.、Biodexa Pharmaceuticals Plc、Tff Pharmaceuticals, Inc.较为活跃,换手率分别为211.82%、55.87%、41.53%,振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc.,振幅分别为38.33%、14.55%、14.30%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223138a24b7542&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223138a24b7542&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTXR"],"gpt_icon":0},{"id":"2484514815","title":"Citius Pharmaceuticals, Inc.盘中异动 股价大涨5.58%报0.203美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484514815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484514815?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:33","pubTimestamp":1732113183,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时33分,Citius Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.58%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp、Forte Biosciences, Inc.涨幅较大,Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为464.50%、184.85%、101.49%,振幅较大的相关个股有Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.、Silexion Therapeutics Corp,振幅分别为30.55%、23.42%、20.16%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022330395be4cf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022330395be4cf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTXR"],"gpt_icon":0},{"id":"2484485928","title":"Citius Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.22%报0.213美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484485928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484485928?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:44","pubTimestamp":1732027463,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时44分,Citius Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.22%。Citius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.61%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Dermata Therapeutics Inc C/Wts 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃,换手率分别为668.04%、85.45%、72.94%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tff Pharmaceuticals, Inc.,振幅分别为70.00%、52.14%、45.03%。Citius Pharmaceuticals, Inc.公司简介:Citius Pharmaceuticals Inc是一家生物制药公司,专注于辅助癌症护理、处方产品和干细胞治疗中的抗感染药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119224423971a76f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119224423971a76f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTXR","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.citiuspharma.com","stockEarnings":[{"period":"1week","weight":-0.0681},{"period":"1month","weight":-0.3879},{"period":"3month","weight":-0.8175},{"period":"6month","weight":-0.8292},{"period":"1year","weight":-0.8623},{"period":"ytd","weight":-0.8625}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Citius Pharmaceuticals, Inc.于2007年1月23日成立为马萨诸塞州有限责任公司Citius Pharmaceuticals,LLC。总部位于新泽西州克兰福德的公司是一家致力于重症监护产品开发和商业化的专业制药公司针对重要的医疗需求,重点是辅助癌症护理和独特处方产品中的抗感染产品。他们的目标是通过提供解决未满足的医疗需求的治疗产品来实现领先的市场地位。以前批准的具有重要安全性和有效性数据的药物的新配方是寻求减少与药物开发相关的发展和临床风险的核心焦点。他们的战略以具有知识产权和监管排他性保护的产品为中心,同时提供优于其他现有治疗方法的竞争优势。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.137229},{"month":2,"riseRate":0.571429,"avgChangeRate":0.062077},{"month":3,"riseRate":0.571429,"avgChangeRate":0.018089},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.007887},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.022546},{"month":6,"riseRate":0.428571,"avgChangeRate":0.053304},{"month":7,"riseRate":0.571429,"avgChangeRate":0.070126},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.112837},{"month":9,"riseRate":0.25,"avgChangeRate":-0.075775},{"month":10,"riseRate":0.25,"avgChangeRate":-0.094985},{"month":11,"riseRate":0.5,"avgChangeRate":-0.054372},{"month":12,"riseRate":0.125,"avgChangeRate":0.024809}],"exchange":"NASDAQ","name":"Citius Pharmaceuticals, Inc.","nameEN":"Citius Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Citius Pharmaceuticals, Inc.(CTXR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Citius Pharmaceuticals, Inc.(CTXR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Citius Pharmaceuticals, Inc.,CTXR,Citius Pharmaceuticals, Inc.股票,Citius Pharmaceuticals, Inc.股票老虎,Citius Pharmaceuticals, Inc.股票老虎国际,Citius Pharmaceuticals, Inc.行情,Citius Pharmaceuticals, Inc.股票行情,Citius Pharmaceuticals, Inc.股价,Citius Pharmaceuticals, Inc.股市,Citius Pharmaceuticals, Inc.股票价格,Citius Pharmaceuticals, Inc.股票交易,Citius Pharmaceuticals, Inc.股票购买,Citius Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Citius Pharmaceuticals, Inc.(CTXR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Citius Pharmaceuticals, Inc.(CTXR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}